Continued triple digit growth from GI Genius®, double digit growth from Winlevi® and steady growth from Gastro and CDMO business. Increased R&D spending to advance Phase II programs for Bile Acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results